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Prolonged Fatigue in Ukraine and the United States: Prevalence and Risk Factors
Abstract
Background: Prolonged, severe, unalleviated fatigue may be disabling whether it occurs on its own or in
conjunction with medical or psychiatric conditions. This paper compares the prevalence and correlates of
prolonged fatigue in general population samples in Ukraine versus the US. Methods: Population surveys
were conducted in 2002 in both Ukraine (Ukraine World Mental Health [WMH] Survey) and the US
(National Comorbidity Survey-Replication; NCS-R). Both surveys administered the Composite International
Diagnostic Interview (CIDI 3.0), which contained modules assessing: neurasthenia (prolonged fatigue);
mood, anxiety, and alcohol/drug use disorders; chronic medical conditions; and demographic
characteristics. Multivariable logistic regression was used to examine risk factors in each country.
Results:
Results:The lifetime prevalence of prolonged fatigue was higher in Ukraine (5.2%) than the US (3.7%). In
both countries, one-fifth of individuals with prolonged fatigue had no medical or DSM-IV psychiatric
condition. Also in both settings, fatigue was significantly associated with socio-demographic
characteristics (being female, not working, and married before) as well as early onset and adult episodes
of mood/anxiety disorder. Fatigue prevalence in Ukraine increased with age, but decreased in the US at
age 70. Unique risk factors for fatigue in Ukraine included lower socio-economic status, Ukrainian versus
Russian ethnicity, and cardiovascular disease. Unique risk factors in the US were parental depression/
anxiety, adult episodes of alcohol/drugs, pain conditions, and other health problems. Conclusions: The
lifetime prevalence of prolonged fatigue in Ukraine was 40% higher than that found in US data. In addition,
fatigue prevalence increased sharply with age in Ukraine perhaps due to limited social and medical
resources and greater comorbidity.
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Abstract
Background: Prolonged, severe, unalleviated fatigue may be disabling whether it occurs on its
own or in conjunction with medical or psychiatric conditions. This paper compares the
prevalence and correlates of prolonged fatigue in general population samples in Ukraine versus
the U.S.
Methods: Population surveys were conducted in 2002 in both Ukraine (Ukraine World Mental
Health [WMH] Survey) and the U.S. (National Comorbidity Survey-Replication; NCS-R). Both
surveys administered the Composite International Diagnostic Interview (CIDI 3.0), which
contained modules assessing: neurasthenia (prolonged fatigue); mood, anxiety, and alcohol/drug
use disorders; chronic medical conditions; and demographic characteristics. Multivariable
logistic regression was used to examine risk factors in each country.
Results: The lifetime prevalence of prolonged fatigue was higher in Ukraine (5.2%) than the
U.S. (3.7%). In both countries, one-fifth of individuals with prolonged fatigue had no medical or
DSM-IV psychiatric condition. Also in both settings, fatigue was significantly associated with
sociodemographic characteristics (being female, not working, and married before) as well as
early onset and adult episodes of mood/anxiety disorder. Fatigue prevalence in Ukraine increased
with age, but decreased in the U.S. at age 70. Unique risk factors for fatigue in Ukraine included
lower socio-economic status, Ukrainian vs Russian ethnicity, and cardiovascular disease. Unique
risk factors in the U.S. were parental depression/anxiety, adult episodes of alcohol/drugs, pain
conditions, and other health problems.

Conclusions: The lifetime prevalence of prolonged fatigue in Ukraine was 40% higher than that
found in U.S. data. In addition, fatigue prevalence increased sharply with age in Ukraine
perhaps due to limited social and medical resources and greater comorbidity.
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comorbidities

Introduction
Prolonged, debilitating fatigue without clear etiology is embodied in two similar conditions,
neurasthenia and chronic fatigue syndrome (CFS). Both conditions feature disabling medically
unexplained fatigue that is associated with the unusual symptom of post-exertional fatigue (or
exhaustion). Neurasthenia appears in the ICD-10 [1] and is characterized by at least 3 months of
persistent and distressing feelings of exhaustion after minor mental or physical effort. Also
required is one additional symptom (muscular aches, sleep disturbance or irritability) and an
inability to recover from exhaustion through rest or relaxation. By comparison, CFS [2] requires
6 months of unremitting fatigue and 4 out of 8 secondary symptoms of which the most frequently
reported are cognitive difficulties, sleep disturbance, and post-exertional malaise [3]. An early
report by Farmer et al. [4] found that 97% of CFS subjects also met ICD-10 criteria for
neurasthenia (without exclusion criteria).
With regard to prevalence, the most recent U.S. population-based study of neurasthenia [5]
estimated lifetime prevalence at 4.9%. CFS lifetime prevalence is considerably lower with a
generally accepted U.S. estimate of about .5% [6, 7]. Both CFS and neurasthenia have been
prospectively linked to prior stressful life events [8-11]. More generally, debilitating prolonged
fatigue is a common feature in a wide variety of conditions, such as chronic inflammatory,
infectious, neurological, and psychiatric diseases as well as cancer [12].
Prolonged fatigue has also been studied in aging populations and may be an early indicator of
the onset of medical conditions. Two large sample investigations in the elderly (ages 65-85) [13,
14] found a high prevalence (18-24%) of self-reported persistent fatigue or lack of energy that
was linked to physical and role impairments. Furthermore, subjective reports of tiredness after

activities in the elderly have been found in several studies [reviewed in 15] to be a strong
independent predictor of functional decline, disability, and death.
Aims
The purpose of this study was to compare the prevalence of prolonged fatigue in Ukraine and
the U.S. using data obtained from the neurasthenia module of Composite International
Diagnostic Instrument (CIDI). More specifically, this paper examined the lifetime prevalence of
neurasthenia in these two countries, and their age-of-onset distributions, patterns of comorbidity,
and sociodemographic correlates. A secondary question concerned the relationships of comorbid
conditions to fatigue in the elderly. Throughout the text, the term “prolonged fatigue” will be
used as a more generic term for neurasthenia and CFS.

Methods
Ukraine Sample
The Ukraine World Mental Health Survey (WMH; 16) and the National Comorbidity SurveyReplication (NCS-R; 17) have been described previously. Briefly, the Ukraine WMH
implemented a four-tiered stratified cluster design to obtain a nationally representative sample of
4,725 adults aged 18 and older (response rate 78.3%). The sample was administered the paperpencil version of the CIDI 3.0, which contains two parts in order to reduce respondent burden.
All 4,725 respondents received Part I, which assessed mood and anxiety disorders and
alcoholism. Part I respondents who met criteria for one or more disorders and a random sample
(16%) of the remaining respondents were administered Part II (N = 1,720). The analysis of
prolonged fatigue used the Part II sample. Weighting procedures allow the generalization of
findings to the population of adults in Ukraine (see Data analysis).

U.S. Sample
The NCS-R was a national probability sample assessed with the computerized version of the
CIDI 3.0 in 2002-2003 (data available from www.icpsr.org). The NCS-R used a multi-stage
cluster sampling design. A total of 9,282 respondents aged 18 and older participated in Part 1 of
the NCS-R (response rate = 73.0%). The Part II sample (N=5962) was the focus of our analysis
of prolonged fatigue. Weighting procedures allow the generalization of findings to the
population of adults in the United States (see Data Analysis).
Instrument
The CIDI 3.0 is a widely administered and reliable structured diagnostic tool designed for use
by lay interviewers. More detail on the CIDI can be obtained elsewhere [18] including
translation details used for the Ukraine CIDI [16].
Prolonged fatigue
Using the Neurasthenia Module of the CIDI, prolonged fatigue was operationalized as
follows: (a) several months or more of weakness, tiredness or exhaustion while performing
minor everyday physical or mental tasks, (b) the tiredness or weakness was not alleviated by
resting or relaxing, (c) during the months or years when the problems were most severe, the
respondent got tired most or nearly every day, and (d) the tiredness had “a lot” or “extreme”
impact on work, social life and/or personal relationships. Lifetime prevalence rates were derived
from participants who fulfilled these criteria.
In comparison to previous studies [e.g., 19], our inclusion criteria specified symptom severity
in addition to presence or absence of each symptom. Information on severity and frequency of
symptoms may yield more accurate prevalence estimates because symptoms are assessed in a
precisely defined and reproducible manner [3]. To ensure that the prevalence of prolonged

fatigue was not driven largely by individuals reporting a cancer diagnosis, which is strongly
linked to fatigue [e.g., 20], we also created a version of the prolonged fatigue diagnosis that
eliminated individuals who reported ever being diagnosed with cancer. There were no other
medical or psychiatric exclusion criteria.
Risk factors
Demographic characteristics, childhood onset (early childhood) factors, and adult episodes of
psychiatric and medical conditions (adult risk factors) were included in the analysis. We
considered seven demographic variables, five of which were identical in the two samples: sex,
age (18-49, 50-69, 70+), employment status (currently working or not currently working),
education (high school or less, beyond high school) and marital status (married before but not
currently, currently married, or never married). Ethnicity and socio-economic status were
constructed differently for the two samples: (1) Ethnicity in the U.S. was dichotomized into
white vs non-white; ethnicity in Ukraine was based on whether the interview was conducted in
Ukrainian versus Russian; (2) socioeconomic status was assessed in the U.S. by household
income of >$65,000 versus <$65,000 and in Ukraine by a rating of family financial status as
adequate (enough money for durables), inadequate (not enough money for clothing) and very
inadequate (not enough money for food).
Four early childhood factors were analyzed using identical variables for the U.S. and Ukraine,
namely, (1) early onset (aged 19 or earlier) of DSM-IV alcohol or drug abuse (substance use
disorder), and of mood or anxiety disorders (depression, dysthymia, (2) generalized anxiety
disorder, panic disorder, social phobia and agoraphobia, (3) parental anxiety or mood disorder
(depressive episodes lasting 2+ weeks that interfered with life activities or episodes of
nervousness or anxiety lasting 1+ month or anxiety/panic attacks), and (4) parental alcoholism

(alcohol problems that interfered with life activities during a significant portion of the
respondent’s childhood). The WMH-CIDI contained special probes designed to maximize recall
of age of onset.
Five adult risk factors were measured identically in the two samples: (1) adult episodes (age
20+) of DSM-IV drug or alcohol abuse (substance use disorder); (2) mood or anxiety disorder
(disorders are identical to list in previous paragraph); (3) cardiovascular health problems (stroke
or heart attack within the last 12 months or lifetime diagnosis of heart disease or high blood
pressure); (4) pain conditions (arthritis or rheumatism, chronic back or neck problems,
frequent/severe headaches or any other chronic pain condition over the past 12 months); and (5)
other major health conditions (asthma, tuberculosis, other chronic lung disease, diabetes, ulcer,
thyroid disease, neurological disorders, epilepsy, kidney disease, and liver disease).
Data analysis
To approximate the population distributions for both Ukraine and the U. S. on key sociodemographic variables and to account for differential probability of selection and non-response
bias into part II, the sample was weighted [16,34,35]. Statistical analyses were conducted using
R statistical software [21] to adjust for the stratified sampling design and sample weights. Odds
ratios and 95% confidence intervals were obtained from binary logistic regression analyses.
Multivariable analyses were conducted in three steps in order to model the temporal progression
of potential risk of prolonged fatigue: (1) Step 1 included the significant (p<0.05) demographic
risk factors; Step 2 added the significant childhood risk factors while retaining significant risk
factors from Step 1; and (3) Step 3 added the adult risk factors while retaining significant risk
factors from Steps 1 and 2.
Results

Demographic characteristics
Table 1 shows the demographic characteristics of the Ukraine and the U.S. samples. Both
samples were relatively evenly split between male and female respondents, while the Ukraine
sample had more years of education but with greater unemployment. Parental, childhood and
adult mental and physical health risk factors tended to be similar between the two samples,
though some modest differences are noted in the table.
Prevalence of Prolonged Fatigue
The lifetime prevalence of neurasthenia, i.e., prolonged fatigue was 5.2% (SE=0.7%;
89/1720) in Ukraine and 3.7% (SE=0.2%; 213/5692) in the U.S. (p<.05). Information on age of
onset and recency of prolonged fatigue was available for 59.8% (n=53) of fatigue cases in
Ukraine and 91.9% (n=196) of cases in the U.S. In Ukraine, the median age of onset was 34.16
(range 10 - 73; IQR 20.4 – 44.87). A total of 2.8% SE=0.3%; 48/1720) of cases reported
prolonged fatigue in the year prior to interview. Among U.S. cases with prolonged fatigue, the
median age of onset was 32.6 (range 6 - 81; IQR 22 - 41). A total of 1.9% (SE=0.2%; 108/5692)
of cases reported prolonged fatigue in the year prior to interview. Lifetime prevalence decreased
only minimally to 5.0% (SE=0.7%; 85/1720) in Ukraine and 3.4% (SE=0.2%; 194/5692) when
excluding individuals with a lifetime diagnosis of cancer. The diagnostic criteria without physical
or mental health exclusions are used throughout the remainder of the manuscript.
Only about one in ten individuals with prolonged fatigue in Ukraine (9.0%) and the U.S.
(11.2%) had no other lifetime physical conditions. Less than one in four individuals with
prolonged fatigue in the U.S. (23.2%) and less than half in Ukraine (39.7%) had no lifetime
psychiatric disorders. We note, however, that these conditions were not necessarily comorbid in
that they did not always occur simultaneously within the same individual.

Bivariate Risk Factors Associations
In both the U. S. and Ukraine, demographic risk factors were significantly associated with
risk of prolonged fatigue (Table 2). In both countries females, individuals not working,
individuals married before (divorced or widowed) and those with lower socio-economic status
were at increased risk of prolonged fatigue. Race and education were not significant factors in
the U.S., but were significant in Ukraine (higher rates of prolonged fatigue in the less educated
and in Ukrainian speakers). Importantly, while age was significantly related (p<.001) to fatigue
in both samples, the pattern of significance was quite different. In Ukraine, fatigue risk increased
linearly across age categories, whereas in the U.S. cohort, there was a sharp decrease in risk in
the age 70+ cohort (Figure 1).
In the United States, all four childhood risk factors, including both parental variables, were
strongly related to lifetime risk of prolonged fatigue with odds ratios ranging from 1.7 (Early
onset Alcohol/Drug) to 3.8 (Early Onset Mood/Anxiety). In Ukraine, only one of the four risk
factors was significant (Mood/Anxiety; OR=2.7 (1.8, 4.0). As with childhood risk factors, all
five adult risk factors showed significant associations with lifetime prolonged fatigue risk in the
U. S. In Ukraine, three of the five adult risk factors were associated with prolonged fatigue risk:
mood/anxiety disorder, cardiovascular health problems and pain conditions (Table 2).
Multivariable analysis
In the multivariable analysis, four demographic variables remained significantly associated
with lifetime risk of lifetime prolonged fatigue after adjusting for the other significant
demographic variables in each sample. Two of the four demographic variables (female and age)
were significant in both samples (Female: U.S., p<.001, UK: p<0.01; Age: U.S., p<.001, UK: p
<.05), while marital status (p<.01) and employment status (p<.001) were significant in the U.S.,

whereas language (p<.05) and income (p<.001) were significant in Ukraine.
After controlling for other childhood and demographic risk factors, only 2 of the 4 risk factors
remained significant for lifetime prolonged fatigue in the U.S. sample: Early Onset
Mood/Anxiety (p<.001) and Parental Anxiety/Depression (p<0.001). Early Onset Mood/Anxiety
was the only significant childhood risk factor in the Ukraine sample (p<.001).
Finally, only adult mood/anxiety disorders was a significant risk factor for prolonged fatigue
in multivariable models for both the U.S. (p<.001) and Ukraine (p<.01). Cardiovascular diseases
was a significant predictor (p<.001) in Ukraine, while adult substance use disorder, pain and
other chronic health conditions were significant predictors (p<.01) in the U.S. Based on
significant risk factors in the multivariable models, Figures 2a and 2b show the cumulative risk
for prolonged fatigue as the total number of risk factors increases in both the U.S. (ten possible
risk factors) and Ukraine (seven possible risk factors) samples.

Discussion
This paper presented findings on the epidemiology of lifetime prolonged fatigue, using a
neurasthenia assessment in the Ukraine (Ukraine-World Mental Health Survey [Ukraine-WMH])
and in the U.S. (2003 National Comorbidity Survey-Replication [NCS-R]). The lifetime
prevalence of neurasthenia (i.e., prolonged fatigue) was found to be 5.2% in Ukraine, about 40%
higher than that found in the U.S. data (3.7%). The female: male ratio for prolonged fatigue
prevalence was about 2:1 in both populations. The 12 month interference with activities such as
housework and ability to work were similar between Ukraine and the U.S., but interference with
close relationships and social life was actually greater (p<0.01 and p<0.01, respectively) in the
U.S. We also found that a higher number of risk factors (e.g., adult mood and anxiety) was

predictive of a higher percentage of individuals reporting fatigue symptoms that fulfilled criteria
for neurasthenia. In addition, prolonged fatigue prevalence spiked in the age 70 and over group
in Ukraine, while U.S. rates declined for the elderly.
Increased risk of prolonged fatigue was linked to females, individuals not working,
individuals married before (divorced or widowed) and those with lower socio-economic status.
In the U.S., whites had higher rates of prolonged fatigue than non-whites. The risk factors for
prolonged fatigue were largely similar between the U.S. and Ukraine, but with higher risk for
individuals with alcohol abuse history in the U.S. sample and for those with lower education in
Ukraine.
In a recent U.S. population study [5], the adjusted prevalence rate for lifetime neurasthenia
without exclusionary criteria was 4.9%. Our lifetime estimates of 3.7-5.2% without exclusionary
criteria are in a comparable range. Our use of symptom severity criteria may have increased the
ability to screen those individuals with clinically significant symptoms.
The Impact of Life Events
Stressful life events have been prospectively linked to both CFS and neurasthenia [8-11]. In
Ukraine, psychological risk factors for prolonged fatigue may in part be a long-range
consequence of a number of potentially traumatic events that have occurred in that region. These
events include the social and economic dislocations following the dissolution of the Soviet
Union in the 1990s, and a large number of industrial, mining, and transport accidents [16], most
notably the Chernobyl nuclear plant accident in 1987.
In related work, new pilot data based on a discrete catastrophic life event (9/11 responders to
the World Trade Center attacks in the U.S.) suggest that the prevalence of prolonged fatigue is
unusually high in this group [22]. Paths from major life events to prolonged fatigue (via

mediation or moderation) may include sleep disturbance, poor social support, ongoing stress,
depression, anxiety [23], and/or medical comorbidities [12]. However, it is not clear how these
intervening variables may exert their putative effects on fatigue severity and incidence. For
instance, stress may directly lead to fatigue or be mediated by sleep disturbance. Furthermore, it
is unclear whether factors such as social support might be able to alter the strength of the life
events–fatigue relationship (i.e., as a moderator).
Psychiatric and medical morbidities
Childhood and adult psychiatric risk factors including mood/anxiety disorder and alcohol
abuse were identified for prolonged fatigue. Because the symptom of fatigue occurs in mood and
anxiety disorders, it has been proposed that prolonged fatigue states such as neurasthenia and
CFS may be somatic variants of psychiatric disorders [24]. However, fatigue appears to be
qualitatively different in prolonged fatigue states because it is worsened by physical and mental
effort, including exercise [25]. By comparison, exercise is a moderately effective treatment for
depression and anxiety [26]. Furthermore, although fatigue may be a feature of anxiety and
depressive disorders, prolonged fatigue can occur in the absence of psychiatric disorder [6, 23].
The high prevalence of chronic medical comorbidities in both the Ukraine and U.S.
samples suggest additional influences on prolonged fatigue states. For instance, fatigue is a
frequent complaint in cardiovascular disease [27], with exertion fatigue particularly prominent in
heart failure [28]. In addition, fatigue may constitute the first clinical manifestation of heart
disease [27]. Similarly, fatigue in the less distinct conditions of neurasthenia and CFS may
capture important elements, including pre-clinical manifestations, of other diseases especially in
older populations [29].
Prolonged fatigue and the elderly

Figure 1 shows the sharply higher percentage of individuals with prolonged fatigue in the age
70 and over group in Ukraine (11.1%) as compared to a much lower rate in the U.S. elderly
subgroup (1.9%). One partial explanation for this higher fatigue prevalence in Ukraine is that
fewer public and private resources are available for health and other services to the elderly. Even
for those elderly with “relative-responsible” families who are providing care, there are often
feelings of profound social and psychological isolation [30]. Less social support has also been
linked to neurasthenia [23].
Furthermore, the post- Soviet decline in health and the increase in chronic medical illness
such as heart disease, diabetes, and cancer [30, 31] may disproportionately impact the elderly.
As such, prolonged fatigue may reflect advancing heart disease as well as undiagnosed
preclinical conditions, physical declines with age, and sedentary activity levels [15].
Limitations
The size of the U.S. sample was nearly twice as large as the Ukraine cohort which increased
the ability to identify significant risk factors and may account for some of the differences
between the two groups. However odds ratio estimates suggest that sample size may not be the
only explanation. Findings in the over 50 group may reflect survivor bias [32], a significant
concern in regions with life expectancy <70, as found in the Ukraine. In addition, memory for
fatigue symptoms and episodes over the lifespan is subject to recall bias that may inflate the
severity of remembered symptoms [33].
Conclusion
Prolonged fatigue as diagnosed with neurasthenia criteria shows considerably higher
prevalence in the Ukraine in comparison to the U.S. Fatigue was associated with both medical
and psychiatric comorbidities, with only a small minority reporting “pure” fatigue without

comorbid conditions. Fatigue prevalence was sharply higher in the elderly in Ukraine in
comparison to the U.S.
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